Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Gilead Sciences (NQ: GILD)
74.47 USD  +1.21 (+1.65%)
Streaming Delayed Price  /  Updated: 3:40 PM EDT, Jun 3, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 10,521,816
Open 74.38
Bid (Size) 74.47 (4)
Ask (Size) 74.48 (1)
Prev. Close 73.26
Today's Range 73.36 - 74.55
52wk Range 60.89 - 85.97
Shares Outstanding 1,300,260,832
Dividend Yield 2.99%
Performance
YTD
+14.17%
+14.17%
1 Month
-7.20%
-7.20%
3 Month
+0.35%
+0.35%
6 Month
+12.71%
+12.71%
1 Year
+16.60%
+16.60%
Top News
More News
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
Financialnewsmedia.com News Commentary Read More
from PR Newswire
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
More News
Read More
Covid-19 Global Race for Testing and Vaccines Sees Biotechnology Innovation
category Financial
from Investorideas.com newswire, breaking stock news and business news
Biotech Stocks Snapshot - Race for Testing and Vaccines for COVID-19 Sees Spike in Biotechnology Innovation
from Newsfile Corp News Releases
Are These The Best Biotech Stocks To Buy Or Avoid This Week?
from Stockmarket.com
Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy
category GILD , Benzinga , Market News , and 12 more.
from Benzinga
Coronavirus update: Global death toll tops 380,000 as Brazil records biggest one-day toll since start of outbreak
category GOOS , Health/Care , Company Announcements/Warnings , and 12 more.
from MarketWatch
Things Are Looking Up For Giant Biotech Stock Gilead — Here's Why
from Investor's Business Daily
Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy
category Healthcare , Stocks / Equities
from Blogs - TalkMarkets
UPDATE 3-India approves Gilead's remdesivir to treat severe COVID-19 cases
category companyNews
from Reuters: Company News
UPDATE 2-India approves Gilead's remdesivir to treat severe COVID-19 cases
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.